Southeast Asia Pen Needles Market (2024-2029)
The Southeast Asia Pen Needles Market was valued at $15.4 Million in 2024 and projected to reach to $20.9 Million by 2029, representing a compound annual growth rate of 5.3%. The Southeast Asia pen needles market is positioned for steady growth driven by escalating diabetes incidence and healthcare modernization initiatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Southeast Asia Pen Needles Market Trends and Insights
- In Middle East & Africa, this growth is driven by rising diabetes prevalence, increasing healthcare infrastructure investment, and growing adoption of injectable diabetes therapies among both urban and emerging populations.
- The region's pen needle market reflects expanding access to modern diabetes management tools, supported by government health initiatives and private sector expansion across key markets. Middle East & Africa's pen needles market is characterized by a gradual shift toward self-administered injectable therapies and improved patient awareness of diabetes care.
- Between 2024 and 2029, Middle East & Africa is expected to see accelerated demand from both developed healthcare systems in the Gulf Cooperation Council (GCC) countries and emerging markets seeking affordable diabetes management solutions.
- The competitive landscape in Middle East & Africa remains fragmented, with opportunities for both established medical device manufacturers and regional players to capture growing demand..
Key Market Statistics
- CAGR (2024-2029) 5.3% CAGR
- Market Size, 2024 ~USD 15.4 Million
- Forecast, 2029 ~USD 20.9 Million
- Country Southeast Asia
Southeast Asia Pen Needles Market Overview
Rising Diabetes Burden :
Southeast Asia faces rapidly increasing diabetes prevalence, with countries like Indonesia, Thailand, and Philippines reporting double-digit growth rates. This surge directly drives demand for convenient injectable delivery systems like pen needles.
Healthcare Infrastructure Expansion :
Governments across Southeast Asia are investing heavily in primary healthcare facilities and diabetes management programs. Improved access to modern medical devices and insulin therapies is accelerating pen needle adoption in both urban and rural regions.
Growing Middle-Class Population :
Expanding middle-class demographics in Vietnam, Malaysia, and Thailand are increasing healthcare spending and willingness to adopt premium diabetes management solutions, supporting market growth at 5.3% CAGR through 2029.
Regulatory Harmonization :
ASEAN regulatory frameworks are becoming more aligned, facilitating faster product approvals and market entry for pen needle manufacturers, creating competitive opportunities across the region's six major markets.
Southeast Asia Pen Needles Market Dynamics
- Countries including Indonesia, Philippines, Thailand, and Vietnam are experiencing significant increases in injectable therapy adoption as healthcare providers emphasize improved glycemic control and patient convenience.
- Government healthcare programs and private sector investments are expanding distribution networks and improving product accessibility. Market expansion will be supported by rising awareness campaigns, physician education programs, and increasing reimbursement coverage for diabetes management devices.
- The region's young, growing population combined with lifestyle changes presents sustained demand opportunities.
- By 2029, Southeast Asia's pen needles market is expected to reach USD 20.9 million, reflecting the region's commitment to addressing its diabetes epidemic through advanced therapeutic delivery solutions..
Related Ecosystem
Drug Delivery Devices
- Disposable Autoinjectors
- Reusable Autoinjectors
- Insulin Pumps
- Pen Injectors
- Transdermal Patches
- Novo nordisk a/s
- Becton, Dickinson and Company
- Terumo Corporation
- Medtronic plc
- Nipro Corporation
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Middle East & Africa pen needles market valued at USD 15.4 million in 2024, growing to USD 20.9 million by 2029 at 5.3% CAGR
- Rising diabetes prevalence and healthcare infrastructure expansion are primary growth drivers in Middle East & Africa
- Middle East & Africa shows increasing adoption of self-administered injectable therapies and improved patient awareness
- Fragmented competitive landscape in Middle East & Africa presents opportunities for both multinational and regional manufacturers
Pen Needles Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | SAFETY PEN NEEDLES (Type) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 9.2% from 2024 to 2029 |
| Largest Segment | STANDARD PEN NEEDLES (Type) |
| Market Size Base Year (Billions) | ~USD 1.82 (2024) |
| Revenue Forecast (Billions) | ~USD 3.08 (2029) |
| Segments Covered | Type, Length, Application, Mode Of Purchase, Care Setting |
Southeast Asia Pen Needles Market Report Segmentation
5 segment dimensions are covered across the global market.
By Type
- Safety Pen Needles
- Standard Pen Needles
By Length
- 10Mm
- 12Mm
- 4Mm
- 5Mm
- 6Mm
- 8Mm
By Application
- Glp-1 Therapy
- Growth Hormone Therapy
- Insulin Therapy
- Osteoporosis
- Other Applications
By Mode Of Purchase
- Online Purchase
- Otc Purchase
- Other Modes Of Purchase
- Prescription-Based Purchase
By Care Setting
- Home Care Settings
- Hospitals & Clinics
- Hospitals And Clinics
- Other End Users
Target Audience
- Medical Device Manufacturers : Pen needle producers and insulin delivery system companies need Southeast Asia market intelligence to identify growth opportunities, assess competitive positioning, and develop localized product strategies for the region's expanding diabetes patient base.
- Healthcare Investors & PE Firms : Investment professionals evaluating healthcare opportunities in Southeast Asia require detailed market sizing, growth projections, and risk assessments to make informed capital allocation decisions in the diabetes management device sector.
- Pharmaceutical Companies : Insulin manufacturers and diabetes therapy providers need market data to understand pen needle adoption rates, distribution channels, and patient preferences across Southeast Asia to optimize their injectable product commercialization strategies.
- Healthcare Distributors & Retailers : Medical device distributors and pharmacy networks require market insights on demand forecasts, regional variations, and competitive dynamics to optimize inventory management and supplier relationships across Southeast Asian markets.
- Government & Healthcare Policy Makers : Healthcare ministries and policy organizations need market intelligence on diabetes prevalence, treatment gaps, and device adoption trends to inform healthcare infrastructure planning and reimbursement policy development across Southeast Asia.
Key Companies in the Southeast Asia Pen Needles Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery in LTAC hospitals,Oral drug administration in inpatient rehabilitation facilities,Contract rehabilitation and outpatient-related drug administration support, |
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automated manufacturing and assembly systems,Lifecycle services and digital/connected factory solutions,Contract manufacturing and value-added integration, |
| ALLERGAN PLC | Ireland | Private Company | Medical Aesthetics & Dermatology,Eye Care,Neuroscience & CNS, |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation delivery devices,Injectable and autoinjector devices,Nasal and other specialty devices, |
| HENRY SCHEIN | United States | Public Company | Global Distribution & Value-Added Services,Global Specialty Products,Global Technology, |
| EMBECTA CORP. | United States | Public Company | Pen needles,Syringes,Safety injection devices, |
| NOVO NORDISK A/S | Denmark | Public Company | GLP-1 for Diabetes (injectable and oral),Obesity Care (GLP-1, including Wegovy pill),Insulin and Smart Pens (NovoPen 6, Echo Plus, needles), |
| YPSOMED | Switzerland | Public Company | Pen injectors,Auto-injectors,Wearable injectors and patch pumps, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| NIPRO | Japan | Public Company | Dialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products,Pharmaceutical-related (generics, kits, CDMO for injectables and oral drugs), |
| ARKRAY, INC. | Japan | Private Company | Diabetes testing & blood glucose monitoring,Urinalysis,Immunodiagnostics, |
| HTL-STREFA | Poland | Private Company | Safety lancets for professional capillary sampling,Personal lancets for home blood glucose monitoring,Pen needles for diabetes therapy, |
| BERPU MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | Regular insulin pen needles,Safety insulin pen needles and pens,Hypodermic and hypo-dermal needles, |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates with 64,200 employees. The company provides healthcare services and related solutions across the United States.
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc. is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ALLERGAN PLC
Allergan PLC is an Ireland-based private company founded in 1983 with 17,400 employees. The company operates in the pharmaceutical and medical aesthetics sectors.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees. The company provides medical device and pharmaceutical delivery solutions.
HENRY SCHEIN
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to medical, dental, and veterinary professionals.
EMBECTA CORP.
Embecta Corp. is a United States-based public company founded in 1924 with 1,850 employees. The company manufactures and distributes diabetes care and medical devices.
NOVO NORDISK A/S
Novo Nordisk A/S is a Denmark-based public company founded in 1923 with 67,900 employees. The company is a global pharmaceutical company specializing in diabetes, obesity, and other chronic diseases.
YPSOMED
Ypsomed is a Switzerland-based public company founded in 1984 with 2,025 employees. The company develops and manufactures injection and infusion systems for diabetes and other therapeutic areas.
TERUMO CORPORATION
Terumo Corporation is a Japan-based public company founded in 1921 with 30,591 employees. The company manufactures and distributes medical devices, blood products, and pharmaceutical solutions globally.
NIPRO
Nipro is a Japan-based public company founded in 1947 with 38,593 employees. The company manufactures and supplies medical devices, pharmaceuticals, and healthcare products worldwide.
ARKRAY, INC.
Arkray, Inc. is a Japan-based private company founded in 1960 with 566 employees. The company manufactures diagnostic and medical devices for healthcare applications.
HTL-STREFA
HTL-Strefa is a Poland-based private company founded in 2000. The company manufactures medical devices and related healthcare products.
BERPU MEDICAL TECHNOLOGY CO., LTD.
Berpu Medical Technology Co., Ltd. is a China-based private company founded in 2000. The company manufactures medical devices and related healthcare solutions.
Reasons to Buy this Report
- Market-Specific Growth Projections : Access detailed forecasts for Southeast Asia's pen needles market with country-level breakdowns for Indonesia, Philippines, Thailand, Vietnam, Malaysia, and Singapore, enabling precise investment and expansion planning.
- Competitive Landscape Analysis : Understand regional market dynamics, key players, distribution channels, and competitive positioning specific to Southeast Asia's unique healthcare ecosystem and regulatory environment.
- Diabetes Prevalence Insights : Gain comprehensive data on diabetes epidemiology across Southeast Asian countries, patient demographics, treatment patterns, and adoption rates for injectable therapies to inform product development strategies.
- Healthcare Infrastructure Assessment : Evaluate government healthcare initiatives, reimbursement policies, hospital networks, and clinic infrastructure across Southeast Asia to identify market entry opportunities and partnership potential.
- Strategic Market Entry Guidance : Leverage region-specific insights on regulatory requirements, distribution partnerships, pricing strategies, and market barriers to develop effective go-to-market strategies for Southeast Asian expansion.
Frequently asked questions
What is the current market size of pen needles in Middle East & Africa?
The Middle East & Africa pen needles market is estimated at USD 15.4 million in 2024.
What is the projected market size for pen needles in Middle East & Africa by 2029?
The Middle East & Africa pen needles market is projected to reach USD 20.9 million by 2029.
What is the CAGR for the pen needles market in Middle East & Africa?
The Middle East & Africa pen needles market is expected to grow at a CAGR of 5.3% from 2024 to 2029.
What are the main drivers of growth in the Middle East & Africa pen needles market?
Key growth drivers in Middle East & Africa include rising diabetes prevalence, expanding healthcare infrastructure, increased adoption of injectable therapies, and improved patient awareness of diabetes management.
Is the Middle East & Africa pen needles market competitive?
Yes, the Middle East & Africa pen needles market is fragmented with opportunities for both established multinational manufacturers and regional players to capture growing demand.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the pen needles market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the pen needles market. Primary sources from the demand side included hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.
A breakdown of the primary respondents for pen needles market (supply side) market is provided below:
Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 3: Other primaries include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size for pen needles market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for pen needles market was calculated using data from three distinct sources, as will be discussed below:
Data Triangulation
The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.
Approach to derive the market size and estimate market growth.
Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of pen needles. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
A pen needle is a hollow needle entrenched in a plastic hub and attached to injectable pens. Pen needles are available in a wide range of lengths and diameters and can be used by healthcare professionals and patients to deliver injectable medications into the patient’s body. Pen needles are electro-polished for smooth, thin, and fine-point tips and provide comfort and ease in penetration; they serve as an alternative drug delivery technique to the traditional method of injecting drugs.
Stakeholders
- Manufacturers of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Original equipment manufacturing companies
- Suppliers and distributors of pen needles, insulin pens, injectable drug delivery devices, and diabetes supplies
- Healthcare service providers
- Teaching hospitals and academic medical centers
- Health insurance players
- Government bodies/municipal corporations
- Regulatory bodies
- Business research and consulting service providers
- Authorities framing reimbursement policies for pen needles
- Venture capitalists
- Market research and consulting firms
Report Objectives
- To define, describe, and forecast the pen needles market based on type, length, application, mode of purchase, setting and region.
- To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall pen needles market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pen needles market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
- To profile the key players and comprehensively analyze their market shares and core competencies in the pen needles market
- To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the pen needles market
- To benchmark players within the pen needles market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings.
Get the Full Pen Needles Market Report
Full forecast, segment splits, and company analysis for all Pen Needles Market.
- Canada Pen Needles Market
- US Pen Needles Market
- Germany Pen Needles Market
- UK Pen Needles Market
- France Pen Needles Market
- Italy Pen Needles Market
- Spain Pen Needles Market
- Japan Pen Needles Market
- China Pen Needles Market
- India Pen Needles Market
- South Korea Pen Needles Market
- Brazil Pen Needles Market
- Mexico Pen Needles Market
- Argentina Pen Needles Market
- GCC Countries Pen Needles Market
- Rest Of Europe Pen Needles Market
- Rest Of Asia Pacific Pen Needles Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
